Instill Science

A place to discuss science, share work, and find mentors and collaborators

Instill Science / post-4M66dbbL
March 2, 2023jessica-sacher
Biotech news Clinical Trial

BiomX Inc. announced positive results from Part 1 of the Phase 1b/2a trial evaluating their novel phage cocktail, BX004, for the treatment of chronic pulmonary infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis.

Loading ...
No comments yet. Be the first to comment!